Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Garcia-Aymerich, I. Serra, D. Mannino, A. Johnston, D. Miller, K. Johnston-Davis (Lexington, Research Triangle Park, United States Of America; Barcelona, Spain). Lung function impairment, COPD hospitalisations and subsequent mortality. Eur Respir J 2009; 34: Suppl. 53, 986

Member's Comments

No comment yet.

Related content which might interest you: Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort Source: Eur Respir J 2006; 28: Suppl. 50, 160s Year: 2006 Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 The main disease-related cost drivers in COPD: impaired lung function and exacerbations Source: Eur Respir J 2003; 22: Suppl. 45, 216s Year: 2003 Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Lung function decline in asthma Source: Eur Respir J 2007; 30: 411-413 Year: 2007 COPD patients with exertional desaturation have a higher risk of rapid lung function decline Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Anemia predicts mortality after COPD exacerbation Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Predictors of mortality in COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Predictors of mortality in COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Standardised mortality rates in females and males with COPD and asthma Source: Eur Respir J 2005; 25: 891-895 Year: 2005 Negative pressure ventilation decreases lung function decline, acute exacerbations and hospitalizations in COPD patients with desaturation during 6 minute walk test Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases Year: 2015 Lung hyperinflation is a determinant of the heart rate recovery delay in COPD patients Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Severe exacerbations predict excess lung function decline in asthma Source: Eur Respir J 2007; 30: 452-456 Year: 2007 Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 Role of comorbidities in stable COPD patients mortality Source: International Congress 2016 – Monitoring comorbidities Year: 2016 COPD mortality after severe exacerbations Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 Factors affecting one year mortality of hospitalized patients with COPD exacerbation and respiratory failure Source: Eur Respir J 2007; 30: Suppl. 51, 321s Year: 2007 In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality Source: International Congress 2015 – COPD: interesting notes Year: 2015 Predictors of mortality in COPD patients after hospitalization due to an exacerbation Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 One-year mortality in COPD patients after severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016